Condition
Acinar Cell Carcinoma
Total Trials
3
Recruiting
2
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 1 (1)
P 2 (1)
Trial Status
Recruiting2
Active Not Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT02834013Phase 2Active Not RecruitingPrimary
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
NCT04657068Phase 1Recruiting
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
NCT02757859Not ApplicableRecruitingPrimary
High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery
Showing all 3 trials